cover letter
TRANSCRIPT
![Page 1: cover letter](https://reader036.vdocuments.us/reader036/viewer/2022083023/58ae42b01a28abad338b5381/html5/thumbnails/1.jpg)
My name is Stephen Elliott and I am a very high performing biotech / pharmaceutical sales person seeking a position in specialty sales. I have significant start-up, orphan / rare drug and specialty experience. I have documented success taking a territory from zero dollars in sales to one that consistently exceeds goals.
I am currently employed at Corcept Therapeutics where I am ranked number two in the company. My production has always greatly exceeded goals in every measurable category. Corcept’s drug,”Korlym,” is an orphan drug indicated for a very rare condition and I have proven I can find patients and retain them once on drug. My performance and patient retention rate is enviable in the orphan / rare drug market. I am a multiple President’s Club winner.
My tenure at Corcept Therapeutics is one of industry leading success. To accomplish such great things, I worked closely with the most incredible team of people. My team consisted of two MSLs, patient advocate, marketing, and reimbursement manager. By leading and being a part of such a great team we saved and enhanced lives, generated revenue for the company and became leaders in the rare disease drug field
I have also started a company where I hired, trained, managed and made payroll for four pharmaceutical sales people with a focus on topical pain management drugs. This comprehensive skill set is quite rare in the biotech/ start-up industry. I learned much about how to build business from the ,”ground up,” and explains why I have been highly successful working for a start-up company.
Your company has the opportunity to hire one of the best in the industry. I bring a skill set that can make your company grow and help many sick patients. We should set up a time to discuss how I can help your organization. My telephone number is 216-695-0670 and email is [email protected]. I look forward to meeting with you soon.
Stephen Elliott